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President-ERIC A. CROOK, M.A., M.Ch., F.R.C.S. [March 6, 1957] DISCUSSION ON HYPOPHYSECTOMY FOR CANCER Mr. Hedley J. B. Atkins (Department of Surgery, Guy's Hospital):
The Value ofHypophysectomy compared with Adrenalectomy for Advanced Cancer of the Breast In 1945 Huggins (Huggins and Dao, 1953) performed total adrenalectomy on a series of patients with advanced cancer of the breast, but as all these patients died, they were not reported and I was unaware of this work when in 1947 I performed subtotal adrenalectomy on a series of 7 patients with advanced cancer of the breast who previously had had bilateral oophorectomy. The impression formed was that if sufficient adrenal tissue was removed to have an effect upon the breast cancer, the hazard to life was so great that it was not worth while doing, and this method of attack was allowed to lapse until it received fresh impetus from the discovery of cortisone which made total adrenalectomy safe. From then on, until 1953 when Luft and Olivecrona (1953) published details of encouraging results from hypophysectomy, adrenalectomy with bilateral oophorectomy became the standard method of treatment for all advanced cases of cancer of the breast for whom no further treatment by direct surgery, radiotherapy or hormone administration was admissible. The results were moderate and were similar to those which have now been reported from many centres all over the world.
Following this period, my colleague Mr. Murray Falconer began to operate upon certain of these cases by hypophysectomy; the choice of the operation being made at this time on grounds of expediency and depending very largely on which doctor sent the patient up and to whom the case was originally sent. It soon became apparent that this method of treatment was at least as likely to succeed as adrenalectomy and we decided in concert with Dr. K. S. MacLean, the Assistant Director of the Department of Medicine at Guy's, and my own assistant, Mr. J. L. Hayward, to compare the results of these two methods of treatment on a scientific basis (Atkins et al., 1957) .
The material which we used came from the Breast Clinic at Guy's, where we see approximately 80 new cases of breast cancer each year. When a suitable patient presented herself and a decision had been made that one or other of these operations was appropriate, the choice was made by a process of random selection. Paired cards, eventually to the number of thirty of each category, were placed in a box and whichever card was withdrawn, that operation was performed. In this way, a completely lunseleted series of 30 cases operated upon by adrenalectomy could be compared with 30 cases operated upon by hypophysectomy. No ethical problem was involved because we were all completely open-minded about the outcome of the investigation and we all would have been willing to have the choice of operation determined in this way had the decision involved our own relatives. It is only in the later stages of such an investigation, when one method of treatment appears to be drawing ahead of the other, that doubts of this sort begin to obtrude, but once started, it would be completely unethical to desist until the matter had been settled one way or the other beyond reasonable doubt.
We were fortunate at the Breast Clinic in that for the last six years we had used a method of assessing the results of treatment on cases of advanced breast cancer devised by Walpole and Paterson (1949) and known as the Mean Clinical Value (M.C.V.). M.C.V. assessment is particularly applicable to those diseases which, like advanced carcinoma of the breast, have many manifestations that show a varying response to treatment. It gives a numerical value to the effect of treatment which enables a clear-cut picture to emerge and one which can be compared statistically with other methods of treatment. The principle is to examine OCTOBER Proceedings of the Royal Society of Medicine all the manifestations of a case about to be treated and to measure them. These measurements may be made upon clinically obtrusive lesions such as lumps in the breast, the glands or the skin, by means of the direct application of calipers and tape measure to the part, or in the case of skeletal lesions they are made from the X-ray photographs. A base-line is thus devised for each lesion and any departure from this base-line as a result of treatment is assessed subsequently at four-weekly intervals. Subjective symptoms, with the exception of pain, are not used as factors in determining response to treatment, and pain is used only if the difference in degree of pain experienced is such as admits of no uncertainty.
Having established a base-line for each feature of the disease, the patient is started on treatment. In the cases under discussion this would be either by adrenalectomy with oophorectomy or by hypophysectomy. At each subsequent four-weekly visit, the lesions are severally assessed. If a lesion has undoubtedly improved it is given a mark of 2; if it has undoubtedly worsened: 0, and if it remains the same, or if there is any doubt: 1. The marks are then added and divided by the number of lesions to give an average mark for the response to treatment of the patient as a whole. The average mark would range between O and 2, and, being an awkward figure to handle, the result is multiplied by the factor 6 so that the range is between 0 and 12. It is this figure which is termed the M.C.V.
Having determined the M.C.V. for a patient at each four-weekly visit during treatment, a chart can be drawn of the patient's progress giving a picture of her response to treatment, impossible to achieve by the most careful description. Moreover, this sequence of numbers can be compared with the sequence of numbers derived from another patient treated perhaps by another method, so that the effect of treatment in the two cases can be readily contrasted.
In this enquiry, the method was extended so that a whole series of sequences derived from 30 patients treated by one method was compared with the whole series derived from the 30 patients treated by the other. In this way, approximately 1,000 integers derived from one series could be compared with 1,000 integers derived from the other and there was a chance that a statistical difference would emerge. Had we used, for instance, the number of months survived as an indication of response to treatment, only one integer would have been available for each patient-namely, the number of months survived. Consequently, in our series 30 integers would be available for comparison with 30 integers and it would be many years before differences could be detected on a statistical scale. Furthermore, the period of survival depends as much on the capricious nature of the siting of the secondaries ;as on their response to treatment. Thus a patient with a secondary in the brain that responded to treatment and then relapsed, might survive six months; whereas a patient with secondaries in the skin which never responded might survive eighteen months. The respective figures allotted to these patients on this basis would then give a misleading impression of the effect of treatment. It is true that in a very large series these anomalies would be ironed out, but it would prolong the investigation to such an extent as to rob it of any practical value.
As it is, our figures derived from the M.C.V. assessment are not conclusive. These figures have been analysed for us by Dr. P. Armitage of the Department of Statistics at the London School of Hygiene and Tropical Medicine, and although they are suggestive that hypophysectomy is to be preferred to adrenalectomy in the treatment of cases of advanced cancer of the breast, they are not statistically significant within the conventional range of 0 05 per cent.
There is, in fact, only a ten to one chance in favour of our results representing a real advantage of hypophysectomy over adrenalectomy, and not the twenty to one, or a hundred to one chance that we should wish to achieve before claiming that this was the case beyond all reasonable doubt.
Nevertheless, it looks very much as though hypophysectomy is going to be the better ,method of treatment; certainly the chances against it being less good than adrenalectomy are very great indeed. It looks as though, if you wish to disturb the rhythm of the endocrine orchestra, it is better to remove the conductor than the first violin.
Destruction of the hypophysis is certainly as effective as any method of treatment available to us at present for treating these desperate cases and it may well be better than any other. Because hypophysectomy is a relatively formidable procedure, two further considerations deserve our notice.
First, are there ways of destroying the hypophysis other than by direct surgical removal?
Can we, as Lawrence and Tobias (1956) have indicated, destroy the hypophysis effectively by pro'ton bombardment? Secondjy, is there not some pre-treatment test that can be applied to these patients to give some indication as to whether they are likely to respond?
860.-'44C'
In our laboratories at Guy's, Allen et at. (1957) have been working on this problem by estimations of the 17-ketosteroid secretion in the urine. If they have not solved this problem, they have certainly demonstrated a most exciting possibility, namely, that within a very short while we shall be able to say-"with this patient, destruction of the hypophysis is. likely to succeed; with that patient it will be unavailing".
Whatever may be the possibilities for the future, I would wish to make the most earnestplea that they should be investigated on a scientific basis from the start and that good ideas should be tested out properly with adequate controls by random selection so that they become established or rejected within a reasonable time and do not linger on for decades until they expire of inanition.
The "radical mastectomy versus McWhirter" controversy is one that must not be repeated..
Because there has been no proper control, we are no nearer the solution to this vexatious matter than we were when it was first mooted in 1942. The place of hypophysectomy in the treatment of advanced cancer of the breast and its. merits relative to other methods of hypophyseal destruction such as stalk section, the implantation of radio-active substances into the sella turcica, and proton bombardment, must be investigated in the spirit which would have informed John Hunter.
Surgeons particularly have been guilty of the gravest laxity of scientific discipline in their approach to therapeutics. We now have the tools, methods and techniques for instituting a neo-Hunterian era; let us do something about it.
Mr. Murray A. Falconer (Guy's-Maudsley Neurosurgical Unit):
Hypophysectomy and Cancer I propose to discuss the technique of hypophysectomy, to illustrate some of its results in advanced cancer of the breast, and to consider briefly its mode of action. Luft and Olivecrona in 1953 must be credited with the first concerted attempt to determine the effects of the operation in patients with cancer. Since then several surgeons have reported their results, notably Bronson Ray in the United States and Radley Smith in this country. There is now general agreement that the operation is only of value in advanced carcinoma of the breast and in a few cases of carcinoma of the prostate. It seems of no value in other tumours such as malignant melanoma, metastatic carcinoma of the gonads, or hypernephroma.
Surgical treatment.-Of the three possible surgical routes to the pituitary gland (transsphenoidal, sub-temporal, and sub-frontal), only the latter gives adequate exposure. The details of operative technique vary from clinic to clinic. We perform a right frontal craniotomy under general aniethesia, and then approach the chiasmal region by lifting the frontal lobe off the anterior cranial fossa, simultaneously sucking cerebrospinal fluid out of the chiasmal cisterns. The chiasmal region has always been readily visualized without recourse to hypotensive techniques, refrigeration aniesthesia, or preliminary lumbar or ventricular drainage. All arachnoidal tissue within the concavity of the chiasma is divided, exposing the pituitary stalk and the diaphragma selle. If the chiasma is prefixed, some extra room can be gained by chiselling off the tuberculum selle. The pituitary stalk can then be cut flush with the diaphragma without prior clipping, for it bleeds very little. Next the diaphragma is incised and the pituitary is then scooped and sucked out, sometimes in one piece, but generally in fragments. Some bleeding from the cavernous sinus surrounding the pituitary fossa may be encountered at this stage, but it is seldom profuse and generally stops spontaneously once the gland is removed. We then usually instil Zenker's fluid on a patty for 2 to 3 minutes, in order to fix any remaining glandular fragments before inserting a quick-setting acrylic plate to prevent reunion of the pituitary stalk to any glandular fragments that may have eluded removal and chemical fixation.
It is our practice to perform this operation under a high cover of cortisone starting with 50 mg. by mouth about six days before operation and working up to 400 mg. on the day of the operation. Following this regime the post-operative management has usually been g62 Proceedings of the Royal Society of Medicine 46 smooth, and the dose of cortisone is decreased in stages to 25 mg. twice daily by mouth on the 8th day, at which it is maintained. Provided the carcinomatous condition permits, the patient is allowed out of bed by the 5th to 8th post-operative day.
Results.-The results of hypophysectomy, in our cases, have been summarized by Mr. Hedley Atkins. All the patients had breast carcinoma with widespread metastases which had failed treatment by stilbeestrol, testosterone, or similar hormones after prior treatment by surgery or irradiation. 20 of the 30 patients showed some improvement in the early stages, but after the sixth month the majority began to show, at varying periods of time, reappearance or progression of their lesions. However, 2 of the 5 patients operated on longer than three years ago are still surviving. Both regressed and one is still without recrudescence, although the other after an interval of two and a half years has exhibited fresh lesions. The results prima facie in the hypophyseotomy group seemed a little better than after adrenalectomy and several have been able to return to a normal life. There were no deaths which could be ascribed to the operation, although three died within a month from the progress of their carcinoma. Certain complications, however, occurred:
(1) In one patient the operation was not practicable owing to an abnormal configuration of the sellar region. This patient was assessed as a failure for the operation, and was subsequently submitted to adrenalectomy.
(2) Some degree of diabetes insipidus developed in most cases, generally within the first post-operative week. Sometimes Pitressin, either as snuff or by injection, was required to control it during the early stages, but in all instances it declined spontaneously within a few weeks or months.
(3) Six patients had bitemporal visual field defects of varying degree on perimetry, but only one complained of her defective vision.
(4) All patients had anosmia on the side of operation, a few had bilateral anosmia.
(5) Most patients in the course of a few weeks became myxcedematous, and were then given thyroid 30 mg. twice daily by mouth.
Mode of action.-In those cases where the operation has failed to halt the disease, or where there has been a recurrence after a remission, a possible inference is that the hypophysectomy has been incomplete. Luft and Olivecrona (1953) , and also Pearson et al. (1956) have accepted depression of the radioactive iodine uptake of the thyroid as evidence of the completeness of the hypophysectomy. In 19 of our cases we made these studies and found values which were consistently depressed to low.or very low levels. Yet in 6 of our cases which came to post-mortem and then had the pituitary fossa carefully sectioned, fragments of anterior pituitary lobe variously estimated at between 1 % and 10% of the total volume of the gland have been found histologically. One of these patients had benefited considerably from the operation and died following an accident some six months later. Thus in her case regression of the disease occurred in spite of the fact that her hypophysectomy was not complete.
It is possible that, in many of our other surviving patients, the hypophysectomy, although extensive, was likewise not complete. It may well be that pituitary stalk section alone can produce comparable results, due to interruption of the portal venous circulation from the hypothalamus to the anterior lobe of the gland. Further experience is required to settle this point. During l955 we treated 45 patients with advanced malignant disease by the implantation of radon seeds into the pituitary fossa, a total dose of 10-20 millicuries (mc.) being inserted by means of a cannula introduced through the nose and sphenoidal sinus (Forrest and Peebles Brown, 1955; Forrest et al., 1956) . Our hope of selectively destroying the pituitary gland was not fulfilled, for the gamma radiations caused damage also to the optic chiasma and hypothalamus, producing serious loss ofvision in 7 of the 45 patients and a high incidence of permanent and severe diabetes insipidus. In two patients who were admitted in coma nine months after implantation, typical radiation changes of fibrinoid necrosis of the hypothalamic blood vessels were found at post-mortem.
However, it was also apparent that, despite these grave disadvantages, a goodxemission of disease could be obtained by this relatively simple method of treatment. No improvement occurred in 5 patients with malignant melanoma, 3 patients with cancer of the uterus, or 1 with sarcoma of the breast, but 10 of the 36 patients with breast cancer had objective improvement in tumour deposits as a result of the hypophyseal irradiation. 5 of these 10 patients are still alive and in remission-an average time of ninety-six weeks after implantation (Table I) . (Average duration of life-5O weeks) Although adjacent structures were damaged, complete necrosis of the pituitary was not found in any of the cases examined post mortem. Sources of gamma radiation would thus seem to be unsatisfactory. However, a radioactive isotope emitting only beta particles holds greater promise. The experimental work of Rasmussen and his associates (1953) with the isotope of yttrium, yttrium9O, and its safe introduction at craniotomy into the human pituitary (Yuhl et al., 1955; Evans, 1957) , suggested that it might prove suitable for insertion by our technique. Yttrium90 has a short half-life of 64 hours (A.E.R.E. Cat., 1957) , and emits only beta particles of high energy (2-2 MeV) which have a maximum tissue range of only 1 1 cm. (Siegel et al., 1956) although owing to the rapid fall-off of the beta radiation the effective range is considerably less. The target substance, yttrium oxide (Y203) is a powder which can be compressed into rods, which when heated to 1,700°C. fuse into a ceramic mass. We use rods of 50 mg. weight (6 3 x 2 3 mm.), which are activated in the atomic pile to 5-6 mc. To obtain a good distribution of radiation within the pituitary, we have modified our director apparatus to allow the simultaneous insertion of two cannulas, one through each nostril. One rod is introduced through each cannula so that they lie symmetrically, one on either side of the mid-line.
[A film was shown to demonstrate the method of preparing the yttrium rods, and the AkR. technique of their implantation: "The Treatment of Advanced Breast Cancer. A Technique for the Implantation of Radioactive Yttrium into the Pituitary Fossa."] Since March 1956, 34 patients with breast cancer have been treated by yttrium implantation of the pituitary. All patients have been in an advanced stage of their disease with multiple and widespread metastases, and were referred to us for treatment only when the radiotherapists considered that other forms of therapy offered no hope of palliation. One patient with massive pulmonary metastases died under anesthesia. 4 patients developed visual defects (Fig. 1 ), but these did not progress and caused only slight disability. While temporary polyuria may occur during the first few weeks after implantation, only two patients have had permanent diabetes insipidus (Fig. 2) . One of these had a visual defect, and in both the rods were placed in the upper part of the fossa. In 4 patients, profuse rhinorrhza commenced 4 to 27 days after implantation. 3 patients were treated by muscle graft at craniotomy (Mr. J. Sloan Robertson), while in the fourth rhinorrhoea ceased, following an attack of meningitis. A post-mortem finding which might have predisposed to rhinorrhoea was a fracture of the sella turcica, doubtless caused by the forcible insertion of the trocar in two places. We now use a diamond steel drill to cut a clean hole in the bone. A guiding sheath is first introduced until its end strikes the outside wall of the pituitary fossa. Through this sheath the cutting tool is inserted to bore a hole in the bone which allows the seed-introducing cannula, but not the guiding sheath, to enter the pituitary fossa. The length of this cannula is such that it will project only three-eighths of an inch beyond the guiding sheath, so that accidental over-penetration cannot occur (Fig. 3) .
Post-mortem examination has been carried out on 7 patients at variable times after implantation. In 2, the gland was completely destroyed (Fig. 4 ) and neither of these had a visual defect, while in a third only a few cells remained in one lobe. The estimated extent of necrosis in the others was 90-95 % of the gland mass.
None of 4 patients who had previously failed to respond to adrenalectomy had any improvement following implantation. In an acromegalic with breast cancer, the large size of the pituitary fossa necessitated an increase of the dose of yttrium to 18 mc.
Our endocrine survey of these patients includes estimates of pituitary (gonadotrophins), adrenal and ovarian (total 17-ketosteroids and their fractions', oestrogens and uropepsins) and thyroid (1131 uptake and serum cholesterol) functions. The effect of withdrawing cortisone maintenance therapy on the clinical state and steroid excretion is also determined. It would appear that the patient may benefit initially despite incomplete destruction of the gland. That later relapse may be associated with recovery of gland function was suggested by the clinical course of 2 patients who initially responded but relapsed nine and eleven months after radon implantation. At the time of their relapse there was evidence of returned pituitary function and both patients had a further remission when the adrenals were removed (Fig. 5, one FIG. 5.-Urinary excretions of cestrogens and 17-ketosteroids in a female with breast cancer before and after removal of the second adrenal gland, the ovaries and one adrenal having been previously removed. Pituitary radon implantation had been carried out nine months previously with initial response followed by relapse. Further regression followed adrenalectomy.
Our aim is to develop a simple method of destroying the pituitary safely and completely. Until this is achieved, pituitary implantation should not be regarded as a satisfactory alternative either for adrenalectomy or for surgical hypophysectomy, except in the debilitated patient.
Mr. E. J. Radley-Smith (Royal Free Hospital):
The indications for hypophysectomy are: widespread cancer of the breast, cancer of the prostate and possibly'malignant melanoma after it has been disseminated. The indication of carcinoma of the breast is well-agreed. Although some centres do not report good results in carcinoma of the prostate, I have found that it does respond in some cases excellently. The world literature on hypophysectomy for malignant melanoma is very scanty and unfavourable but in view of the difference between my own findings and those of others on carcinoma of the prostate, it is perhaps justifiable to gain further experience by applying this operation to malignant melanoma.
The methods of destruction of the pituitary gland are numerous and I personally combine as complete a surgical removal as is possible with the subsequent insertion of unscreened radio-active gold.
I agree with Mr. Murray Falconer that the pituitary can be removed surgically by retracting the frontal lobe and sucking out the basal cisterns, and I have not found it necessary to institute drainage of the ventricles or the lumbar sac. While I agree with him that retraction of the frontal lobe does give good access-and I did this in at least the first 50 cases-I am now considering that it should be replaced by partial resection of the right frontal pole. Retraction of the frontal lobe, particularly when some of the superior cerebral veins have to be coagulated, may lead to hemorrhage into the substance of the frontal lobe especially if some unsuspected metastases are present in the lobe. This is a point in favour of resection of the frontal pole and part of the frontal lobe. Anosmia is distressingly frequent although the operation is on one side only and retracting and stretching of the olfactory apparatus must be a factor. I have tried section of the pituitary stalk only in one case, and a favourable response was obtained. When relapse occurred some months later, the pituitary gland was surgically removed. No new connection between stalk and gland had been established; histology showed that there was much surviving tissue in the gland which had been cut off from the stalk for several months.
Whereas in the Guy's-Maudsley Unit an attempt has been made to compare the benefits of hypophysectomy with those of adrenalectomy, at the Royal Free Hospital we have approached this matter from a totally different angle. While we have endeavoured to confer benefit on the patients by this operation, we have also used it as a method of learning more about the physiology of the pituitary gland and the biochemical control of patients after its removal. I am glad to acknowledge the extremely generous help from the British Empire Cancer Campaign which has enabled us to employ full-time research workers in this subject.
Patients after hypophysectomy are, I think, a good deal more easily managed and in less danger than after adrenalectomy. Indeed, one of my patients after hypophysectomy withstood a laminectomy without any more effect than would have been produced in a normal person. Another returned to hospital many months later for the removal of an acute appendix and at that operation one was able to observe the regression of the enlarged liver and its secondaries which had caused jaundice at the time of the removal of the pituitary. I agree with Mr. Falconer that the extreme diuresis following operation generally subsides.
With regard to results, in the early work on this subject cases, however unfavourable, were subjected to operation and this accounts for some of the early deaths after operation. Of -those patients who survived operation for more than three months, 84% showed subjective improvement,and 56 objctive improvement. Although in some series subjective improvement is not even considered, I feel that it should not be ignored. In many, the pain from bone secondaries was abolished immediately after operation, although they later succumbed without X-ray evidence of recalcification of the secondary deposits. This relief from severe pain is worthy of comment.
Among the 56% who have improved objectively there has been the disappearance of jaundice, the return of a very large liver to normal and the disappearance of skin secondaries both near and distant from the primary growth. Malignant effusions in the peritoneal, pleural and pericardial cavities are not always abolished at once, if at all, but the intervals between aspirations which may have been as short as ten days before operation may be as long as three months afterwards. In a few cases serial biopsies have shown histological evidence of regression.
It is clear that we still know next to nothing about the results of this operation, but the results in the first 60 have been more than sufficiently encouraging to suggest that the work should continue. We are still hoping that the investigations will one day enable us to tell which cases will respond well to the operation and which will not. At the moment we merely have some indications of those who are going to respond well but we are disinclined to reject any case with the exception of the moribund. The use of hypothermia has made the operation much easier and has given the patients a much calmer convalescence.
Mr. W. P. Greening (Royal Marsden Hospital):
The purpose of this paper is to discuss the effect of beta radiation, using yttrium90, on the human hypophysis; and to show whether the transphenoidal insertion of yttrium90 rods, in an attempt to destroy the pituitary gland, is either a justifiable or worthwhile procedure.
We think that interstitial irradiation of the pituitary has a definite place in the treatment of selected cases. It is not a substitute for ablative surgery but an alternative procedure for those patients where a high operative mortality is expected, if they are subjected to a major operation.
Complete destruction of the gland is desirable but not essential, and worthwhile remissions may be obtained, with relief of symptoms, when a large part is destroyed.
Since metastatic cancer of the breast inevitably terminates in death, it would be as well to review the different methods of treatment at present available.
Galton, in 1950, published a report dealing with 70 cases of breast cancer treated by androgens. All his patients were in an advanced stage of the disease and were completely unselected.
He reported a failure rate of 50%, a success rate, described as successful or moderately successful, giving a combined total of over 40%. He said that of the 30 patients deriving benefit from the treatment, 21 obtained a remission lasting six months or more, 10 over one year and 3 over eighteen months. His maximum success rate was between the ages of 45 and 50, but a similar, though smaller, peak occurred between the ages of 35 and 40. Improvement following cestrogen therapy in the post-menopausal patients is of a similar order.
Cade, in 1954, in an assessment of the results of adrenalectomy in a series of 36 patients, gave a complete absence of response in 29 %, a very successful rate of 23 % and a less successful, though still improved, rate of 31 %. He gives an extended survival of up to twenty months, and remarks that successful results were achieved in about 52 % of the patients.
The results of hypophysectomy as reported by Luft (Olivecrona and Luft, 1957) , Pearson et al. (1956) and Kennedy (1956) show a slight increase in the success rate and a mortality corresponding favourably with that of adrenalectomy. However, in Luft's series hypophysectomy was achieved in only a few cases, and there has been a considerable improvement in his recent results, due to complete removal of the gland. The series reported by Kennedy was carefully selected, and this may account for the high rate of remission.
This remarkable uniformity of results obtained by varying methods of treatment, indicates that hormone responsiveness in breast cancer is limited to half of the patients.
Only 5 women out of 10 will benefit from any method which alters the endocrine balance. These facts make it necessary to balance the magnitude of the treatment against the result that may reasonably be expected.
A mortality of 6% in both adrenalectomy and hypophysectomy, and a morbidity rate in the latter operation of similar proportions is inevitable. In both operations adrenal rests and ectopic hypophyseal tissue may be present in a significant number of cases. Any minor procedure, therefore, tolerated with ease by the patient and accompanied by a low mortality and morbidity, must be worth considering.
It seemed that a small group of patients with metastatic breast cancer who, because of their poor general condition were considered unsuitable for ablative surgery, might benefit from interstitial irradiation of the pituitary, and we were, in the first place, trying to devise a method of either completely or almost completely destroying the gland, without the hazards or inconvenience of a major operation. 50 patients, unsuitable or unfit for adrenalectomy, and possibly therefore for surgical hypophysectomy, were treated by interstitial irradiation of the pituitary using unscreened radio-active gold. As this form of treatment was regarded only as temporary palliation, every effort was made to avoid complications caused by damage to the neighbouring structures, and to select carefully the patients who might be hormone responsive.
The activity of the gold seeds used in these cases was increased from a low value at first up to 20 mc. towards the end of the series. The destruction of the gland was inadequate but the complications were few. They were damage to the parasellar nerves in 3 cases, two VI nerve and one III nerve palsy. There was one case of cerebrospinal rhinorrhcea.
The success rate and duration of the remission so produced was not considered good enough to justify continuing on these lines. For the last 30 cases we have used yttrium9o, because it is a pure beta emitter and has a short half-life of 64 hr. The yttrium9o rods used are made of sintered yttrium oxide, and are 1-3 mm. diameter, and 4 0 mm. long. Each source has an activity of approximately 3 mc. at the time of implantation.
Investigations by a combination of film and ionization chamber techniques show that along the perpendicular axis, the half-value layer of tissue is 0 7 mm. It has also been shown that with an activity of 3 mc. the total dose is approximately 70,000 rad at 3 mm. from the rod; the necrotic boundary has been found to lie at this distance in a number of post-mortem sections of the hypophysis, and is a spherical volume of complete necrosis surrounded by normal tissue. The boundary transition between normal and necrotic tissue is extremely narrow. In this series a success rate of 40% has been obtained, a figure not dissimilar to those produced by endocrine therapy and ablative surgery, although it is already apparent that the length of the remission is probably shorter.
The immediate operative mortality has been 3 %, but few of these cases would have been .even remotely considered fit for adrenalectomy.
One patient developed cerebrospinal rhinorrhcea and one died of meningitis eight weeks after operation. There was no apparent cause for this at post-mortem, the floor of the sella was intact and the pituitary almost completely destroyed. There are two unilateral III nerve palsies in this series, and one unilateral optic atrophy. The urinary gonadotrophin in the cases treated by yttrium90 is estimated before, and at monthly intervals after, the operation, using the method developed in the Clinical Endocrinology Research Unit in the University of Edinburgh, and we are indebted to Dr. L. A. Loraine and Professor Boyland for help and advice with these estimations.
The biological assay is based on the method of Klinefelter, Albright and Griswold, 1943 , depending on the enlargement of the uterus of intact immature mice, 20-22 days old weighing 8-10 grams.
We find that 80% of cases show that gonadotrophin is completely eliminated from the urine post-operatively, in amounts detectable by this bio-assay.
In considering the technique of implanting the yttrium, the following criteria must be satisfied:
(1) There must be accurate insertion into the hypophysis.
(2) The dose must be sufficient to cause necrosis of the gland but not to affect the surrounding structures.
(3) It should be capable of being done quickly and easily without damage to the floor of the sella turcica.
(4) Unless these conditions are completely satisfied the operation should not be undertaken. We use an image intensifier working in two planes. In the lateral view there is no difficulty but we find that a modified Townes' view in the antero-posterior projection is of great value in locating the sella. Following the operation, in most cases little discomfort is experienced, but in some, aspirin or codeine is necessary to relieve headaches for the first few post-operative days.
The patient is kept on antibiotic cover both before and after the procedure. Cortisone is withheld until there are signs of adrenal insufficiency. They appear at about the seventh day and are loss of appetite, nausea and vomiting. They cease as soon as cortisone is administered.
Transient diabetes insipidus occurs in most cases between the second and third weeks. We think that damage to the chiasma or surrounding structures can be completely eliminated by accurate placing of the rods under fluoroscopic control.
